English
13 (1) 2018
Phân tích tổng hợp: Mối tương quan giữa tính chất methyl hóa vượt mức vùng promoter gen GSTP1 (Glutathione S-Transferase P1) với bệnh ung thư vú
Tác giả liên hệ, Email:Tóm tắt
Từ khóa
Tài liệu tham khảo
Arai, T., Miyoshi, Y., Kim, S. J., Taguchi, T., Tamaki, Y., & Noguchi, S. (2006). Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Breast Cancer Research and Treatment, 100(2), 169-176.
Bhat, A., Masood, A., Wani, K. A., Bhat, Y. A., Nissar, B., Khan, N. S., & Ganai, B. A. (2017). Promoter methylation and gene polymorphism are two independent events in regulation of GSTP1 gene expression. Tumor Biology, 39(4), 1-11. doi:10.1177/1010428317697563.
Dejeux, E., Rønneberg, J. A., Solvang, H., Bukholm, I., Geisler, S., Aas, T., & Tost, J. (2010). DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response. Molecular Cancer, 9(1), Article 68.
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., ... Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359-E386.
Ford, M. E., & Kelly, P. A. (2005). Conceptualizing and categorizing race and ethnicity in health services research. Health Services Research, 40(5p2), 1658-1675.
Globocan. (2012). Latest world cancer statistics Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed. Retrieved October 10, 2017, from International Agency for Research on Cancer website: https://www.iarc.who.int/wp-content/uploads/2018/07/pr223_E.pdf
Hafez, M. M., Al-Shabanah, O. A., Al-Rejaie, S. S., Al-Harbi, N. O., Hassan, Z. K., Alsheikh, A., … Sayed-Ahmed, M. M. (2015). Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females. Asian Pacific Journal of Cancer Prevention, 16(2), 541-549.
Haidich, A. B. (2010). Meta-analysis in medical research. Hippokratia, 14(Suppl 1), 29-37.
Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ: British Medical Journal, 327(7414), 557-560.
Hoque, M. O., Feng, Q., Toure, P., Dem, A., Critchlow, C. W., Hawes, S. E., ... & Yu, M. (2006). Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. Journal of Clinical Oncology, 24(26), 4262-4269.
Hughes, E. G. (1996). Systematic literature review and meta-analysis. Seminars in Reproductive Endocrinology, 14(2), 161-169.
Isgor, Y. G., & Isgor, B. S. (2011). Kinases and glutathione transferases: Selective and sensitive targeting. Frontiers in Biology, 6(2), 156-169.
Jerónimo, C., Costa, I., Martins, M. C., Monteiro, P., Lisboa, S., Palmeira, C., ... Lopes, C. (2003). Detection of gene promoter hypermethylation in fine needle washings from breast lesions. Clinical Cancer Research, 9(9), 3413-3417.
Jones, P. A., & Baylin, S. B. (2002). The fundamental role of epigenetic events in cancer. Nature Reviews Genetics, 3(6), 415-428.
Jung, E. J., Kim, I. S., Lee, E. Y., Kang, J. E., Lee, S. M., Kim, D. C., ... Park, S. T. (2013). Comparison of methylation profiling in cancerous and their corresponding normal tissues from Korean patients with breast cancer. Annals of Laboratory Medicine, 33(6), 431-440.
Klajic, J., Fleischer, T., Dejeux, E., Edvardsen, H., Warnberg, F., Bukholm, I., ... Kristensen, V. N. (2013). Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors. BMC Cancer, 13(1), Article 456.
Lasabova, Z., Tilandyova, P., Kajo, K., Zubor, P., Burjanivova, T., Danko, J., & Plank, L. (2010). Hypermethylation of the GSTP1 promoter region in breast cancer is associated with prognostic clinicopathological parameters. Neoplasma, 57(1), 35-40.
Lee, J. S. (2007). GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Archiv, 450(6), 637-642.
Matuschek, C., Bölke, E., Lammering, G., Gerber, P. A., Peiper, M., Budach, W., ... Bojar, H. (2010). Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. European Journal of Medical Research, 15(7), 277-286.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Prisma Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), Article e1000097.
Müller, H. M., Widschwendter, A., Fiegl, H., Ivarsson, L., Goebel, G., Perkmann, E., ... Widschwendter, M. (2003). DNA methylation in serum of breast cancer patients. Cancer Research, 63(22), 7641-7645.
Park, S. Y., Kwon, H. J., Lee, H. E., Ryu, H. S., Kim, S. W., Kim, J. H., ... Kang, G. H. (2011). Promoter CpG island hypermethylation during breast cancer progression. Virchows Archiv, 458(1), 73-84.
Parrella, P., Poeta, M. L., Gallo, A. P., Prencipe, M., Scintu, M., Apicella, A., ... Rabitti, C. (2004). Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clinical Cancer Research, 10(16), 5349-5354.
Phuong, T. K., Thao, D. T. P., Thuan, L. D., & Thuy, L. H. A. (2016). Sự methyl hóa vượt mức tại đảo CpG thuộc vùng promoter của gen GSTP1 là một đặc tính đặc trưng của bệnh ung thư vú người Việt Nam [The excessive methylation at CpG island in the promoter region of the GSTP1 gene is a characteristic feature of Vietnamese breast cancer]. Tạp chí Phát triển Khoa học và Công nghệ, 18(3T), 99-104.
Pongtheerat, T., Pakdeethai, S., Purisa, W., Chariyalertsak, S., & Petmitr, S. (2011). Promoter methylation and genetic polymorphism of glutathione S-transferase P1 gene (GSTP1) in Thai breast-cancer patients. Asian Pacific Journal of Cancer Prevention, 12(10), 2731-2734.
Rønneberg, J. A., Tost, J., Solvang, H. K., Alnaes, G. I., Johansen, F. E., Brendeford, E. M., ... Gabrielsen, O. S. (2008). GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas. Cancer Research, 68(14), 5562-5571.
Russo, M. W. (2007). How to review a meta-analysis. Gastroenterology & Hepatology, 3(8), 637-642.
Ryan, R. (2014). Heterogeneity and subgroup analyses in Cochrane Consumers and Communication Group reviews: Planning the analysis at protocol stage. Retrieved November 15, 2017, from Cochrane Consumers and Communication Review Group webite: http://cccrg.cochrane.org
Saxena, A., Dhillon, V. S., Shahid, M., Khalil, H. S., Rani, M., Das, T. P., ... Shukla, N. K. (2012). GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Experimental and Therapeutic Medicine, 4(6), 1097-1103.
Senior, P. A., & Bhopal, R. (1994). Ethnicity as a variable in epidemiological research. BMJ: British Medical Journal, 309(6950), 327-330.
Shakeri, H., Gharesouran, J., Fakhrjou, A., Esfahani, A., & Ardebili, S. M. M. (2016). DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification. EXCLI Journal, 15, 11-20.
Shargh, S. A., Hosseini, Z. M., & Sakizli, M. (2011). Evaluation of methylation status in glutation S-transferase P1 (GSTP1) gene promoter in human breast cancer and its relation to tumor grade and stage. Scientific Research and Essays, 6(27), 5741-5749.
Sharma, G., Mirza, S., Yang, Y. H., Parshad, R., Hazrah, P., Gupta, S. D., & Ralhan, R. (2009). Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Analytical Cellular Pathology, 31(6), 487-500.
Shinozaki, M., Hoon, D. S., Giuliano, A. E., Hansen, N. M., Wang, H. J., Turner, R., & Taback, B. (2005). Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clinical Cancer Research, 11(6), 2156-2162.
Sturgeon, S. R., Balasubramanian, R., Schairer, C., Muss, H. B., Ziegler, R. G., & Arcaro, K. F. (2012). Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Epigenetics, 7(11), 1258-1267.
Sunami, E., Shinozaki, M., Sim, M. S., Nguyen, S. L., Vu, A. T., Giuliano, A. E., & Hoon, D. S. (2008). Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. Breast Cancer Research, 10(3), Article R46.
Tang, J., Zhou, Q., Zhao, F., Wei, F., Bai, J., Xie, Y., & Huang, Y. (2015). Association of glutathione S-transferase T1, M1 and P1 polymorphisms in the breast cancer risk: a meta-analysis in Asian population. International Journal of Clinical and Experimental Medicine, 8(8), Article 12430.
Terry, M. B., McDonald, J. A., Wu, H. C., Eng, S., & Santella, R. M. (2016). Epigenetic biomarkers of breast cancer risk: Across the breast cancer prevention continuum. Novel Biomarkers in the Continuum of Breast Cancer, 882, 33-68.
The Nordic Cochrane Centre (Cochrane). (2014). Review Manager . Copenhagen: The Nordic Cochrane Centre.
Wang, T., Arifoglu, P., Ronai, Z. E., & Tew, K. D. (2001). Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. Journal of Biological Chemistry, 276(24), 20999-21003.
Wu, L., Shen, Y., Peng, X., Zhang, S., Wang, M., Xu, G., ... Lu, C. (2016). Aberrant promoter methylation of cancer-related genes in human breast cancer. Oncology Letters, 12(6), 5145-5155.
Yamamoto, N., Nakayama, T., Kajita, M., Miyake, T., Iwamoto, T., Kim, S. J., ... Noguchi, S. (2012). Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay. Breast Cancer Research and Treatment, 132(1), 165-173.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.